Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tonix Pharm Hld (TNXP)

Tonix Pharm Hld (TNXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tonix Pharm Hld 26 MAIN STREET SUITE 101 CHATHAM NJ 07928 USA

P: 212-980-9155 F: 212-923-5700

Description:

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.

Key Statistics

Overview:

Market Capitalization, $K 404,893
Shares Outstanding, K 323,914
Annual Sales, $ 0 K
Annual Net Income, $ -28,620 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,990 K
60-Month Beta 1.35
% of Insider Shareholders 0.13%
% of Institutional Shareholders 2.38%
Float, K 323,493
% Float 99.87%

Growth:

1-Year Return 222.52%
3-Year Return -99.63%
5-Year Return -99.95%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.30%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/23/21
Earnings Per Share ttm -0.69
EPS Growth vs. Prev Qtr 60.87%
EPS Growth vs. Prev Year 98.42%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 11/01/19

TNXP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -0.29
Price/Earnings to Growth N/A
Return-on-Equity % -107.52%
Return-on-Assets % -96.64%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.69
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar